DENTSPLY SIRONA Inc. is a global enterprise specializing in the production and distribution of a diverse range of dental products and advanced technologies, primarily serving the professional dental sector worldwide.
Dentsply Sirona stock last closed at $10.45, up 3.06% from the previous day, and has decreased 34.4% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.28 percentage points. Dentsply Sirona stock is currently +11.05% from its 52-week low of $9.41, and -38.85% from its 52-week high of $17.09.
At the moment, there are 200.33M XRAY shares outstanding. The market value of XRAY is $2.09B. In the past 24 hours, 4.93M XRAY shares were traded.
How to Buy Dentsply Sirona Stock
Wondering how to invest in Dentsply Sirona stock? Here's how.
Figure out where to buy Dentsply Sirona stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you decide where to buy Dentsply Sirona stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Put funds into your brokerage account: Choose your method of payment and add your info.
Research Dentsply Sirona stock: The Dentsply Sirona ticker symbol is XRAY. Is Dentsply Sirona stock a good investment? Should you buy shares of XRAY? How do XRAY's underlying business fundamentals look? Do top analysts think Dentsply Sirona is a good buy? Why has XRAY's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if XRAY is a good stock to buy).
Place your XRAY purchase: Decide if you will purchase XRAY shares at the current market price or use a limit order to buy XRAY shares at a given price.
Keep an eye on your investment in XRAY: Create a watchlist to monitor your new investment in Dentsply Sirona shares.
Step 1: Figure out where to buy Dentsply Sirona stock
You need an online brokerage account in order to access the NASDAQ market and buy XRAY stock.
A brokerage account is an investment account that allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our research, eToro is the best stock brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world markets: From Tech to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal information so you can invest in XRAY stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Dentsply Sirona stock
Once you have selected the best place to buy Dentsply Sirona stock, it's absolutely critical to evaluate their stock prior to investing, so you actually comprehend the risk as well as the opportunity.
Dentsply Sirona Metrics
XRAY Price
$10.45
1w %
-0.19%
1y %
-34.4%
5y %
-84.05%
P/E
-3.33x
P/B
1.59x
P/S
0.57x
PEG
N/A
Revenue
$3.68B
Earnings
-$628.00M
Fore. Rev. Growth
1.19%
Fore. Earn. Growth
N/A
Market Cap
$2.09B
Next Earnings
Aug 6, 2026
Next Dividend
N/A
Dentsply Sirona Fundamentals
WallStreetZen was created to help average investors do more accurate fundamental analysis quickly.
XRAY profit margin has gone up from -24.4% to -17.1% in the past year.
There are more short-term assets than short-term liabilities on the XRAY balance sheet.
Failed Financial Due Diligence Checks:
XRAY has a relatively high debt to equity ratio of 2.97.
There are more long-term liabilities than short-term assets on the XRAY balance sheet.
Total XRAY debt is higher than 5 years ago, relative to shareholder equity.
XRAY's operating cash flow of $268.00M allows it to safely service it's debt of $2.33B.
XRAY earnings of -$480.00M is not sufficient to cover its interest payments.
Is it a good time to buy XRAY stock, according to analysts?
Out of 9 Wall Street analysts who monitor XRAY, the consensus analyst rating on XRAY is a Hold
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent XRAY Analyst Forecasts
Vik Chopra, a top 29% analyst from Wells Fargo maintains XRAY with a hold rating and raises their XRAY price target from $12.00 to $13.00, on Feb 27, 2026.
Elizabeth Anderson, a top 26% analyst from Evercore ISI Group maintains XRAY with a hold rating and raises their XRAY price target from $12.00 to $15.00, on Feb 27, 2026.
Jeffrey Johnson, a bottom 38% analyst from Baird maintains XRAY with a hold rating and raises their XRAY price target from $12.00 to $14.00, on Feb 27, 2026.
Michael Cherny, a top 13% analyst from Bank of America upgrades XRAY to a strong buy rating and raises their XRAY price target from $13.00 to $17.00, on Feb 19, 2026.
Bank of America's Michael Cherny upgraded their rating on Dentsply Sirona (NASDAQ: XRAY) from Hold to Strong Buy on 2026/02/19. The analyst also raised their price target by 30.8% from $13 to $17.
Dentsply Sirona will report its Q4 and FY 2025 earnings on 2025/02/26.
Upgrading the stock and raising their price target in a preview note, Cherny said that management's upcoming guidance "could be a clearing event" such that the risk/reward on the stock "finally skews positive."
The print could cause volatility if management cuts the dividend, commits to elevated investments, and introduces consensus-missing guidance, the analyst noted.
Cherny called any post-print dip in the stock price an attractive buying opportunity because "those decisions and progress in repairing distributor relationships could support medium-term growth stabilization."
Last year, XRAY revenue was $3.68B. In the last five year, XRAY's revenue has increased by 1.15% per year. This was slower than the Medical Instruments & Supplies industry average of 10.05%.
No, Dentsply Sirona doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your XRAY purchase
There are two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are mostly fine for most investors.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a given dollar amount, place a limit order.
Hit the Open button and your broker will execute your order.
If you want more help with investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Dentsply Sirona share?
As of Jun 16, 2026, it costs $10.45 to buy one share of Dentsply Sirona stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $5, you can buy 0.478 shares of XRAY.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.